Literature DB >> 23061761

Relevance of HLA compatibility in living donor liver transplantation: the double-edged sword associated with the patient outcome.

Hideaki Uchiyama1, Hiroto Kayashima, Rumi Matono, Ken Shirabe, Tomoharu Yoshizumi, Toru Ikegami, Yuji Soejima, Toshiharu Matsuura, Tomoaki Taguchi, Yoshihiko Maehara.   

Abstract

HLA compatibility in living donor liver transplantation (LDLT) seems relevant to the acceptability of graft livers because LDLT recipients often share most or some part of HLAs with the respective donors. This study retrospectively investigated whether HLA compatibility affected the outcome of LDLT. Three hundred ninety LDLTs were performed in this hospital, and 346 pairs of HLAs (HLA-A, B, DR) were retrieved from the medical record between October 1996 and March 2011. The dates of the deaths were censored when a recipient apparently died of or was retransplanted by other causes than graft failure because of host-versus-graft (HVG) response to purely analyze the outcomes of LDLT in view of HVG response. The relationship between HLA compatibility and graft-versus-host disease (GVHD) was also analyzed. No recipients with recipient-against-donor HLA mismatch (R→D MM) 0 experienced graft failure by HVG response. On the other hand, three of five recipients with "R→D MM 0" together with "donor-against-recipient MM 3" died of fatal GVHD. HLA compatibility in LDLT not only affected the long-term acceptance of graft livers but also the risk of fatal GVHD.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23061761     DOI: 10.1111/ctr.12019

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  4 in total

1.  MHC universal cells survive in an allogeneic environment after incompatible transplantation.

Authors:  Constança Figueiredo; Dirk Wedekind; Thomas Müller; Stefanie Vahlsing; Peter A Horn; Axel Seltsam; Rainer Blasczyk
Journal:  Biomed Res Int       Date:  2013-10-09       Impact factor: 3.411

2.  Cytokine and human leukocyte antigen (HLA) profile for graft-versus-host disease (GVHD) after organ transplantation.

Authors:  Xinhua Chen; Xueqin Meng; Yuning Xu; Haiyang Xie; Shengyong Yin; Hongchun Li; Liming Wu; Shusen Zheng
Journal:  Eur J Med Res       Date:  2016-10-12       Impact factor: 2.175

3.  Superior Outcomes and Reduced Wait Times in Pediatric Recipients of Living Donor Liver Transplantation.

Authors:  Mohit Kehar; Rulan S Parekh; Jennifer Stunguris; Maria De Angelis; Krista Van Roestel; Anand Ghanekar; Mark Cattral; Annie Fecteau; Simon Ling; Binita M Kamath; Nicola Jones; Yaron Avitzur; David Grant; Vicky Lee Ng
Journal:  Transplant Direct       Date:  2019-02-27

4.  Experimental orthotopic transplantation of a tissue-engineered oesophagus in rats.

Authors:  Sebastian Sjöqvist; Philipp Jungebluth; Mei Ling Lim; Johannes C Haag; Ylva Gustafsson; Greg Lemon; Silvia Baiguera; Miguel Angel Burguillos; Costantino Del Gaudio; Antonio Beltrán Rodríguez; Alexander Sotnichenko; Karolina Kublickiene; Henrik Ullman; Heike Kielstein; Peter Damberg; Alessandra Bianco; Rainer Heuchel; Ying Zhao; Domenico Ribatti; Cristián Ibarra; Bertrand Joseph; Doris A Taylor; Paolo Macchiarini
Journal:  Nat Commun       Date:  2014-04-15       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.